First cardiac bioimplants for the treatment of patients with myocardial infarction using umbilical cord stem cells
The results of a pioneering study by IGTP and BST support the safety of the bioimplants called PeriCord, made from stem cells of the umbilical cord and pericardium from a tissue donor, which aid in the regeneration and revascularisation of the affected area.